MYSAFEMEDS - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 86144545
Serial Number
86144545
Word Mark
MYSAFEMEDS
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2015-01-12
Filing Date
2013-12-16
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
BRACEY, KAREN E
Statements
Goods and Services
Computer service, namely, providing an interactive website featuring technology that allow users to manage and maintain personalized records of medications, over-the-counter drugs and nutraceuticals
Pseudo Mark
MY SAFE MEDS
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2013-12-28
Primary Code
042
Correspondences
Name
NOLAND J. CHEUNG
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2013-12-19NEW APPLICATION ENTERED IN TRAM
2013-12-28NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2013-12-31NOTICE OF PSEUDO MARK E-MAILED
2014-03-24ASSIGNED TO EXAMINER
2014-03-25NON-FINAL ACTION WRITTEN
2014-03-25NON-FINAL ACTION E-MAILED
2014-03-25NOTIFICATION OF NON-FINAL ACTION E-MAILED
2014-05-30TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-05-30CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-05-30TEAS/EMAIL CORRESPONDENCE ENTERED
2014-06-16NON-FINAL ACTION WRITTEN
2014-06-16NON-FINAL ACTION E-MAILED
2014-06-16NOTIFICATION OF NON-FINAL ACTION E-MAILED
2015-01-12ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2015-01-12ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND